36247756|t|Targeting the gut microbiome in the management of sepsis-associated encephalopathy.
36247756|a|Brain injury resulting from sepsis, or sepsis-associated encephalopathy (SAE), occurs due to impaired end-organ perfusion, dysregulated inflammation affecting the central nervous system (CNS), blood-brain barrier (BBB) disruption, mitochondrial dysfunction, oxidative stress, accumulation of toxic neuropeptides and impaired toxin clearance secondary to sepsis-induced hepatic and renal dysfunction. The gut microbiome becomes pathologically altered in sepsis, which likely contributes to the pathogenesis of SAE. Herein, we review the literature detailing dysregulation of microbiota-gut-brain axis (MGBA) in SAE and highlight potential therapeutic strategies to modulate the gut microbiome to mitigate sepsis-induced brain injury.
36247756	50	82	sepsis-associated encephalopathy	Disease	MESH:D065166
36247756	84	96	Brain injury	Disease	MESH:D001930
36247756	112	118	sepsis	Disease	MESH:D018805
36247756	123	155	sepsis-associated encephalopathy	Disease	MESH:D065166
36247756	157	160	SAE	Disease	MESH:D065166
36247756	220	232	inflammation	Disease	MESH:D007249
36247756	315	340	mitochondrial dysfunction	Disease	MESH:D028361
36247756	438	444	sepsis	Disease	MESH:D018805
36247756	453	482	hepatic and renal dysfunction	Disease	MESH:D008107
36247756	537	543	sepsis	Disease	MESH:D018805
36247756	593	596	SAE	Disease	MESH:D065166
36247756	694	697	SAE	Disease	MESH:D065166
36247756	788	794	sepsis	Disease	MESH:D018805
36247756	803	815	brain injury	Disease	MESH:D001930

